| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.04 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | 0.073 | 0.04 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.04 |
| mRNA | CEP-701 | FIMM | pan-cancer | AAC | -0.39 | 0.04 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.072 | 0.04 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.04 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.54 | 0.04 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | -0.07 | 0.04 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.092 | 0.05 |